Skip to main content
Latest News
December 19, 2025
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 18, 2025
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 11, 2025
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 11, 2025
09:00 AM ET
Virtual Investor Presentation on Hematology Programs
Webcast
(opens in new window)
View the presentation
December 4, 2025
09:00 AM ET
Citi’s 2025 Global Healthcare Conference
Webcast
(opens in new window)
October 30, 2025
08:00 AM ET
Bristol Myers Squibb Q3 2025 Results Conference Call
Webcast
(opens in new window)
Press Release (PDF)
Quarterly Package of Financial Information (XLS)
Q3 2025 Results Presentation (PDF)
Q3 2025 Results Presentation (with Appendix) (PDF)
Preliminary Q3 2025 Acquired IPRD & Licensing Income (PDF)